DD143906A5 - Trianzin-derivate - Google Patents

Trianzin-derivate Download PDF

Info

Publication number
DD143906A5
DD143906A5 DD79213155A DD21315579A DD143906A5 DD 143906 A5 DD143906 A5 DD 143906A5 DD 79213155 A DD79213155 A DD 79213155A DD 21315579 A DD21315579 A DD 21315579A DD 143906 A5 DD143906 A5 DD 143906A5
Authority
DD
German Democratic Republic
Prior art keywords
phenyl
formula
group
alkyl
methyl
Prior art date
Application number
DD79213155A
Other languages
German (de)
English (en)
Inventor
Edward D Brown
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of DD143906A5 publication Critical patent/DD143906A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/38—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/42—One nitrogen atom
    • C07D251/46—One nitrogen atom with oxygen or sulfur atoms attached to the two other ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DD79213155A 1978-05-26 1979-05-25 Trianzin-derivate DD143906A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2293878 1978-05-26

Publications (1)

Publication Number Publication Date
DD143906A5 true DD143906A5 (de) 1980-09-17

Family

ID=10187501

Family Applications (1)

Application Number Title Priority Date Filing Date
DD79213155A DD143906A5 (de) 1978-05-26 1979-05-25 Trianzin-derivate

Country Status (24)

Country Link
US (1) US4254122A (pt)
EP (1) EP0005911B1 (pt)
JP (1) JPS54154779A (pt)
AT (1) ATE698T1 (pt)
AU (1) AU529948B2 (pt)
CA (1) CA1108138A (pt)
CS (1) CS213377B2 (pt)
DD (1) DD143906A5 (pt)
DE (1) DE2962124D1 (pt)
DK (1) DK213179A (pt)
ES (1) ES480932A1 (pt)
FI (1) FI66180C (pt)
GR (1) GR68185B (pt)
HU (1) HU180252B (pt)
IE (1) IE49170B1 (pt)
IL (1) IL57324A (pt)
MW (1) MW1379A1 (pt)
NO (1) NO791722L (pt)
NZ (1) NZ190402A (pt)
PH (1) PH14793A (pt)
PT (1) PT69650A (pt)
ZA (1) ZA792247B (pt)
ZM (1) ZM4579A1 (pt)
ZW (1) ZW9179A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8629567D0 (en) * 1986-12-10 1987-01-21 Boots Co Plc Therapeutic agents
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
AU7080298A (en) * 1997-04-25 1998-11-24 Takeda Chemical Industries Ltd. Triazine derivatives, their production and agrochemical composition
US6335339B1 (en) 1998-01-13 2002-01-01 Scriptgen Pharmaceuticals, Inc. Triazine antiviral compounds
JP2005532295A (ja) * 2002-04-17 2005-10-27 メディカル リサーチ カウンシル 月経過多を治療するためのＦＰレセプターアンタゴニスト又はＰＧＦ２αアンタゴニスト
CA2533846C (en) * 2003-07-29 2012-08-28 Universitaetsklinikum Muenster Means and methods for treating a disease which is associated with an excess transport of hyaluronan across a lipid bilayer
US7199156B2 (en) * 2003-10-10 2007-04-03 Milos Chvapil Composition and method to treat solid tumors
TW200517114A (en) * 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
WO2007139753A2 (en) * 2006-05-22 2007-12-06 Combinatorx, Incorporated Methods and compositions for the treatment of diseases or conditions associated with increased c-reactive protein, interleukin-6, or interferon-gamma levels
WO2009038708A1 (en) * 2007-09-19 2009-03-26 Combinatorx, Incorporated Therapeutic regimens for the treatment of immunoinflammatory disorders
CN101938996A (zh) * 2007-12-17 2011-01-05 康宾纳特克斯公司 用于治疗免疫炎症性紊乱的治疗方案
PL2399910T3 (pl) * 2009-02-13 2014-09-30 Shionogi & Co Pochodne triazyny jako antagoniści receptora p2x3 i/albo p2x2/3 i kompozycja farmaceutyczna zawierająca je
US9212130B2 (en) 2010-08-10 2015-12-15 Shionogi & Co., Ltd. Heterocyclic derivative and pharmaceutical composition comprising the same
RU2565073C2 (ru) * 2010-08-10 2015-10-20 Сионоги Энд Ко., Лтд. Триазиновое производное и включающая его фармацевтическая композиция, обладающая анальгетической активностью
JP6124351B2 (ja) 2012-02-09 2017-05-10 塩野義製薬株式会社 複素環および炭素環誘導体
TWI637949B (zh) 2013-06-14 2018-10-11 塩野義製藥股份有限公司 胺基三衍生物及含有其等之醫藥組合物
WO2022162689A1 (en) * 2021-01-26 2022-08-04 Council Of Scientific And Industrial Research Triazine-based self-assembling system

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3983116A (en) * 1973-04-05 1976-09-28 E. I. Du Pont De Nemours And Company Herbicidal triazines
US4035365A (en) * 1973-11-01 1977-07-12 Imperial Chemical Industries Limited Triazinediones
GB1543037A (en) * 1975-02-05 1979-03-28 Ici Ltd Selective herbicidal triazine-diones
GB1464248A (en) 1973-11-01 1977-02-09 Ici Ltd Substituted triazinediones their preparation and use as herbicides
US4082536A (en) * 1973-11-01 1978-04-04 Imperial Chemical Industries Limited Heterocyclic compounds and their use as pesticides
GB1504304A (en) * 1974-02-15 1978-03-15 Ici Ltd Process of combating fungal and bacterial infections of plants with triazine dione derivatives
GB1599518A (en) * 1977-02-21 1981-10-07 Ici Ltd 1,3,5-triazine-2,6-diones and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
ZM4579A1 (en) 1981-05-21
PT69650A (en) 1979-06-01
AU4694979A (en) 1979-11-29
DE2962124D1 (en) 1982-03-25
DK213179A (da) 1979-11-27
IE49170B1 (en) 1985-08-21
AU529948B2 (en) 1983-06-30
ES480932A1 (es) 1980-02-01
GR68185B (pt) 1981-11-09
US4254122A (en) 1981-03-03
NO791722L (no) 1979-11-27
NZ190402A (en) 1982-05-31
MW1379A1 (en) 1981-04-08
CS213377B2 (en) 1982-04-09
FI66180B (fi) 1984-05-31
CA1108138A (en) 1981-09-01
EP0005911B1 (en) 1982-02-17
FI66180C (fi) 1984-09-10
JPS54154779A (en) 1979-12-06
ATE698T1 (de) 1982-03-15
IL57324A (en) 1983-10-31
PH14793A (en) 1981-12-09
ZA792247B (en) 1980-05-28
EP0005911A1 (en) 1979-12-12
FI791670A (fi) 1979-11-27
IE790889L (en) 1979-11-26
ZW9179A1 (en) 1981-01-21
IL57324A0 (en) 1979-09-30
HU180252B (en) 1983-02-28

Similar Documents

Publication Publication Date Title
DD143906A5 (de) Trianzin-derivate
DE2614406C2 (pt)
DE69330715T2 (de) Antitumor quinazoline
EP0031080A1 (de) 2-Acylaminomethyl-1,4-benzodiazepine und deren Salze sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0647231B1 (de) N-substituierte 3-azabicyclo[3.2.0]heptan-derivate als neuroleptika usw.
DE2037693A1 (de) Chinazolinderivate,verfahren zu ihrer herstellung und ihre verwendung
EP0022078B1 (de) Pyrazolochinoline, Verfahren zu ihrer Herstellung, und pharmazeutische Präparate enthaltend diese Verbindungen
DE60304599T2 (de) Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
CH644857A5 (de) Piperazinylchinazolin- und homopiperazinylchinazolinderivate sowie verfahren zu deren herstellung und solche derivate enthaltende arzneimittel.
EP0000220B1 (de) Dihydrouracile, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DD158401A5 (de) Verfahren zur herstellung eines 1-substituierten spiro[imidazolidin-4,3'-indolin]-2,2',5-trions
DE2256392A1 (de) Verfahren zur herstellung neuer heterocyclischer verbindungen
DE1770372A1 (de) Neue Indolinderivate und Verfahren zu ihrer Herstellung
DE2807381A1 (de) Pharmazeutische zusammensetzung mit einem gehalt an einem 1,3,5-triazin- 2,6-dion
EP0271099A2 (de) Substituierte Aminopropionsäureamide, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und ihre Verwendung sowie die bei der Herstellung anfallenden neuen Zwischenprodukte
DE3785987T2 (de) Imidazol-derivate und deren salze, verfahren zu deren herstellung, deren anwendung als arzneimittel und deren zusammensetzungen.
EP0025501B1 (de) Neue N-Aminoalkylindol-Derivate und ihre Salze; Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3129718C2 (pt)
DE3780438T2 (de) N-substituierte cyclische amine, ihre herstellung sowie pharmazeutische zusammensetzungen die sie enthalten.
DE2342880A1 (de) Piperazin-pyrimidine, verfahren zu ihrer herstellung und ihre verwendung
EP0084155B1 (de) (1,2)-anellierte 1,4-Benzodiazepin-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0393499A1 (de) Verfahren zur Herstellung von Carbovir und neue Zwischenprodukte dafür
DE2511599A1 (de) Pyrroldiazepine und verfahren zu ihrer herstellung
DE2439284A1 (de) Neue aminopyrrol-derivate
DE69329052T2 (de) Verfahren zur Herstellung von Antifolaten 4-Hydroxypyrrolo 2,3-d pyrimidinderivaten